China's medical supplies supply securitycapabilities continue to enhance

　　He Yaqiong, director of the ConsumerGoods Industry Department of the Ministry of Industry and InformationTechnology, said recently that China has efficiently built a unified commandsystem, production system, collection and storage system and scheduling system,normalize the work of key medical supplies, continue to carry out emergencyduty duty, focus on increasing capacity, stable production, coordinate multipleresources, and promote the medical supplies supply security capacity has beenenhanced to effectively protect the epidemic prevention and control needs.

　　For the recent domestic epidemicmulti-point distribution, frequent occurrence in many places, He Yaqiong said,the first time to communicate with the provinces where the epidemic occurred,strengthen the production of new coronavirus detection reagents, protectivesupplies, therapeutic drugs and vaccines and other key medical suppliesscheduling, close tracking and monitoring of the production and supply of keyenterprises. So far, the antigen detection key production enterprises weeklyproduction capacity of more than 500 million copies, N95 / KN95 mask keyproduction enterprises weekly production capacity of more than 100 million,protective clothing key production enterprises weekly production capacity ofmore than 3 million pieces, the new coronavirus vaccine annual productioncapacity of more than 7 billion doses, production of more than 5.5 billiondoses, to meet the needs of the current epidemic prevention and controlsituation.

　　He Yaqiong said, will continue to improvethe production scheduling and supply of key medical supplies to strengthen thesupply and demand for accurate docking, to ensure timely and adequate supply;closely track the progress of new detection reagents, therapeutic drugs andvaccine development and marketing, timely guidance to enterprises to preparefor large-scale production; support enterprises to carry out internationalcooperation, to assist developing countries to enhance local productioncapacity, to make more for the global fight against the new crown pneumoniaepidemic China's contribution.

　　He Yaqiong revealed that it willaccelerate the implementation of the "14th Five-Year Plan" for thedevelopment of the pharmaceutical industry, accelerate the industrialization ofinnovative achievements, carry out actions to strengthen the pharmaceuticalindustry chain and complement the chain, focus on weak links, support upstreamand downstream enterprises in the industry chain to carry out collaborativeresearch, continue to improve the manufacturing level of the pharmaceuticalindustry, and build a number of high-standard API centralized production base .